COPD patients often experience depression and anxiety, which are complex disorders linked to the disease. These conditions, characterized by bronchial blockage, recurrent coughing, and dyspnea, are a significant global contributor to mortality and morbidity. Treatment options include medication, psychotherapy, and exercise, but there is limited evidence that treating psychiatric disorders leads to better COPD outcomes. Depression and anxiety are significant psychological disorders that can significantly impact COPD patients' experience and management. Cognitive behavioral therapy (CBT) is the first line of psychotherapy for elderly COPD patients, while selective serotonin reuptake inhibitors (SSRIs) are recommended for depression or anxiety. Clinicians must be familiar with screening techniques for these diseases to improve healthcare outcomes. It also examines neuropsychiatric disease assessment and therapy, and it offers suggestions for better diagnostic procedures and care. The conclusions imply that medical professionals treating patients with COPD should become proficient in recognizing these co-occurring disorders and prospective future interventions may have an effect on these individuals and so enhance the course of COPD.
